No price history available.

Based on consensus from external analysts. Not Kvantra's opinion.

Joincare Pharmaceutical Group Industry Co., Ltd. is a Chinese enterprise primarily focused on the comprehensive process of researching, developing, producing, and commercializing pharmaceutical and healthcare products within China. The company boasts a broad pharmaceutical portfolio that includes both Western chemical drug preparations, addressing conditions such as respiratory, gastrointestinal, anti-infection, gonadotropic, and psychiatric disorders, as well as traditional Chinese medicines (TCM), with offerings for anti-tumor and cold relief. Beyond finished drugs, Joincare supplies chemical active pharmaceutical ingredients (APIs) and intermediates. Its operations also extend into the diagnostics sector, where it provides specialized reagents and equipment, such as an autoimmunity multiple detection platform and an IgM diagnostic kit. Furthermore, the company markets a range of health and wellness products, exemplified by American ginseng tea and Jingxin menocare essence. Joincare diversifies its business by engaging in the wholesale and retail of personal care items, including skincare products, cosmetics, and various other essential goods. Its products are available in diverse formats, such as hormone tablets, oral liquid formulations, and standard tablets. Established in 1992, Joincare Pharmaceutical Group maintains its principal offices in Shenzhen, China.

• Hypera S.A.
• Almirall, S.A.
• Supernus Pharmaceuticals, Inc.
• Jamjoom Pharmaceuticals Factory Company
• Jiangsu Nhwa Pharmaceutical Co., Ltd.
• China Resources Double-Crane Pharmaceutical Co.,Ltd.
• ApicHope Pharmaceutical Co., Ltd
• Chengdu Kanghong Pharmaceutical Group Co., Ltd